CN102250829A - 人脐带间充质干细胞向肝细胞定向分化的诱导方法 - Google Patents
人脐带间充质干细胞向肝细胞定向分化的诱导方法 Download PDFInfo
- Publication number
- CN102250829A CN102250829A CN2011101795322A CN201110179532A CN102250829A CN 102250829 A CN102250829 A CN 102250829A CN 2011101795322 A CN2011101795322 A CN 2011101795322A CN 201110179532 A CN201110179532 A CN 201110179532A CN 102250829 A CN102250829 A CN 102250829A
- Authority
- CN
- China
- Prior art keywords
- umbilical cord
- cell
- piece
- stem cells
- cord tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003954 umbilical cord Anatomy 0.000 title claims abstract description 78
- 238000000034 method Methods 0.000 title claims abstract description 29
- 210000002901 mesenchymal stem cell Anatomy 0.000 title claims abstract description 28
- 210000005229 liver cell Anatomy 0.000 title claims abstract description 24
- 230000004069 differentiation Effects 0.000 title claims abstract description 22
- 230000001939 inductive effect Effects 0.000 title claims description 23
- 210000000130 stem cell Anatomy 0.000 claims abstract description 34
- 210000004027 cell Anatomy 0.000 claims abstract description 22
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims abstract description 11
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 claims abstract description 6
- 229960003957 dexamethasone Drugs 0.000 claims abstract description 5
- 230000009194 climbing Effects 0.000 claims abstract description 3
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 claims description 12
- 239000000243 solution Substances 0.000 claims description 10
- 230000006698 induction Effects 0.000 claims description 9
- 235000015097 nutrients Nutrition 0.000 claims description 9
- 229910000147 aluminium phosphate Inorganic materials 0.000 claims description 6
- 239000000872 buffer Substances 0.000 claims description 6
- 206010028980 Neoplasm Diseases 0.000 claims description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 4
- 239000012888 bovine serum Substances 0.000 claims description 4
- 210000002249 digestive system Anatomy 0.000 claims description 4
- 239000000706 filtrate Substances 0.000 claims description 4
- 206010020718 hyperplasia Diseases 0.000 claims description 4
- 239000003112 inhibitor Substances 0.000 claims description 4
- 238000000926 separation method Methods 0.000 claims description 4
- 102000004877 Insulin Human genes 0.000 claims description 3
- 108090001061 Insulin Proteins 0.000 claims description 3
- 102000002070 Transferrins Human genes 0.000 claims description 3
- 108010015865 Transferrins Proteins 0.000 claims description 3
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 claims description 3
- 238000005516 engineering process Methods 0.000 claims description 3
- 230000001605 fetal effect Effects 0.000 claims description 3
- 150000002505 iron Chemical class 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 229960001471 sodium selenite Drugs 0.000 claims description 3
- 239000011781 sodium selenite Substances 0.000 claims description 3
- 235000015921 sodium selenite Nutrition 0.000 claims description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 2
- 108010019160 Pancreatin Proteins 0.000 claims description 2
- 210000004369 blood Anatomy 0.000 claims description 2
- 239000008280 blood Substances 0.000 claims description 2
- 238000013016 damping Methods 0.000 claims description 2
- 239000012530 fluid Substances 0.000 claims description 2
- 239000007788 liquid Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 229940055695 pancreatin Drugs 0.000 claims description 2
- 239000011734 sodium Substances 0.000 claims description 2
- 239000011780 sodium chloride Substances 0.000 claims description 2
- 239000006228 supernatant Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 102000009024 Epidermal Growth Factor Human genes 0.000 abstract 1
- 101800003838 Epidermal growth factor Proteins 0.000 abstract 1
- MVORZMQFXBLMHM-QWRGUYRKSA-N Gly-His-Lys Chemical compound NCCCC[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CC1=CN=CN1 MVORZMQFXBLMHM-QWRGUYRKSA-N 0.000 abstract 1
- 238000012136 culture method Methods 0.000 abstract 1
- 238000012258 culturing Methods 0.000 abstract 1
- 229940116977 epidermal growth factor Drugs 0.000 abstract 1
- 102000009027 Albumins Human genes 0.000 description 12
- 108010088751 Albumins Proteins 0.000 description 12
- 102000007330 LDL Lipoproteins Human genes 0.000 description 7
- 108010007622 LDL Lipoproteins Proteins 0.000 description 7
- 230000008569 process Effects 0.000 description 7
- 230000000694 effects Effects 0.000 description 6
- 102100033420 Keratin, type I cytoskeletal 19 Human genes 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 5
- 238000001976 enzyme digestion Methods 0.000 description 5
- 102000006354 HLA-DR Antigens Human genes 0.000 description 4
- 108010058597 HLA-DR Antigens Proteins 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 230000001079 digestive effect Effects 0.000 description 4
- 101710183399 Keratin, type I cytoskeletal 19 Proteins 0.000 description 3
- 230000024245 cell differentiation Effects 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 102000029816 Collagenase Human genes 0.000 description 2
- 108060005980 Collagenase Proteins 0.000 description 2
- 101000998011 Homo sapiens Keratin, type I cytoskeletal 19 Proteins 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000004913 activation Effects 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000003399 chemotactic effect Effects 0.000 description 2
- 229960002424 collagenase Drugs 0.000 description 2
- 210000001671 embryonic stem cell Anatomy 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 238000010166 immunofluorescence Methods 0.000 description 2
- 230000005847 immunogenicity Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 1
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 description 1
- 102000000853 LDL receptors Human genes 0.000 description 1
- 108010001831 LDL receptors Proteins 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000002458 cell surface marker Substances 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000000254 damaging effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 208000019423 liver disease Diseases 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000029052 metamorphosis Effects 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 238000009256 replacement therapy Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000002459 sustained effect Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101795322A CN102250829B (zh) | 2011-06-29 | 2011-06-29 | 人脐带间充质干细胞向肝细胞定向分化的诱导方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2011101795322A CN102250829B (zh) | 2011-06-29 | 2011-06-29 | 人脐带间充质干细胞向肝细胞定向分化的诱导方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102250829A true CN102250829A (zh) | 2011-11-23 |
CN102250829B CN102250829B (zh) | 2012-07-11 |
Family
ID=44978400
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2011101795322A Expired - Fee Related CN102250829B (zh) | 2011-06-29 | 2011-06-29 | 人脐带间充质干细胞向肝细胞定向分化的诱导方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102250829B (zh) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586183A (zh) * | 2012-01-12 | 2012-07-18 | 天津和泽干细胞科技有限公司 | 一种体外诱导人脐带间充质干细胞高表达Nurr1基因的方法 |
CN103396985A (zh) * | 2013-08-08 | 2013-11-20 | 哈尔滨埃文斯干细胞应用技术有限公司 | 诱导人脐带间充质干细胞分化为肝细胞的方法与应用 |
WO2015010417A1 (zh) * | 2013-07-25 | 2015-01-29 | 中国科学院广州生物医药与健康研究院 | 利用确定的细胞因子组合促进成纤维细胞转分化为脂肪细胞 |
CN104694462A (zh) * | 2015-03-17 | 2015-06-10 | 奥思达干细胞有限公司 | 一种胚胎干细胞定向诱导分化为肝细胞的方法 |
CN106075586A (zh) * | 2016-07-19 | 2016-11-09 | 东华大学 | 基于成体干细胞‑再生丝素蛋白组织工程支架的人工肝修复材料的培养方法 |
CN106119190A (zh) * | 2016-06-30 | 2016-11-16 | 吉林省中科生物工程股份有限公司 | 抑瘤素m在制备促进间充质干细胞体外定向分化为骨细胞的产品中的应用 |
CN106754367A (zh) * | 2016-12-12 | 2017-05-31 | 吉林大学 | 通过静电纺丝制备载药细胞爬片的方法 |
CN108823148A (zh) * | 2018-07-23 | 2018-11-16 | 广东唯泰生物科技有限公司 | 一种脂肪间充质干细胞诱导分化为肝脏样细胞的方法 |
JP2021514680A (ja) * | 2018-03-29 | 2021-06-17 | エースソステム バイオストラテジーズ インコーポレイテッド | ヒト臍帯から幹細胞を分離する方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1844373A (zh) * | 2006-04-28 | 2006-10-11 | 华东理工大学 | 由脐带血造血干细胞体外诱导肝细胞生成的方法 |
CN101033463A (zh) * | 2006-12-21 | 2007-09-12 | 浙江省绍兴市人民医院 | 一种成体干细胞体外跨越分化肝细胞的方法 |
-
2011
- 2011-06-29 CN CN2011101795322A patent/CN102250829B/zh not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1844373A (zh) * | 2006-04-28 | 2006-10-11 | 华东理工大学 | 由脐带血造血干细胞体外诱导肝细胞生成的方法 |
CN101033463A (zh) * | 2006-12-21 | 2007-09-12 | 浙江省绍兴市人民医院 | 一种成体干细胞体外跨越分化肝细胞的方法 |
Non-Patent Citations (3)
Title |
---|
《世界华人消化杂志》 20080528 闫俊卿等 人脐带间充质干细胞生物学特性及向类肝细胞的分化 1639-1644 1 第16卷, 第15期 * |
《中国组织工程研究与临床康复》 20091203 迟作华等 Differentiation of human umbilical cord blood-mesenchymal stem cells into hepatocyte-like cells using in vitro combination of various growth differentiation factors 中文摘要和第9797页右栏第2段-第9798页左栏第2段 1 第13卷, 第49期 * |
《山东大学学报(医学版)》 20090630 张辉等 人脐带间充质干细胞的无动物血清培养及向肝细胞诱导分化 第89页1.2方法 1,3 第47卷, 第6期 * |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102586183A (zh) * | 2012-01-12 | 2012-07-18 | 天津和泽干细胞科技有限公司 | 一种体外诱导人脐带间充质干细胞高表达Nurr1基因的方法 |
WO2015010417A1 (zh) * | 2013-07-25 | 2015-01-29 | 中国科学院广州生物医药与健康研究院 | 利用确定的细胞因子组合促进成纤维细胞转分化为脂肪细胞 |
CN103396985A (zh) * | 2013-08-08 | 2013-11-20 | 哈尔滨埃文斯干细胞应用技术有限公司 | 诱导人脐带间充质干细胞分化为肝细胞的方法与应用 |
CN104694462B (zh) * | 2015-03-17 | 2018-02-13 | 奥思达干细胞有限公司 | 一种胚胎干细胞定向诱导分化为肝细胞的方法 |
CN104694462A (zh) * | 2015-03-17 | 2015-06-10 | 奥思达干细胞有限公司 | 一种胚胎干细胞定向诱导分化为肝细胞的方法 |
CN106119190A (zh) * | 2016-06-30 | 2016-11-16 | 吉林省中科生物工程股份有限公司 | 抑瘤素m在制备促进间充质干细胞体外定向分化为骨细胞的产品中的应用 |
CN106075586B (zh) * | 2016-07-19 | 2019-05-24 | 东华大学 | 基于成体干细胞-再生丝素蛋白组织工程支架的人工肝修复材料的培养方法 |
CN106075586A (zh) * | 2016-07-19 | 2016-11-09 | 东华大学 | 基于成体干细胞‑再生丝素蛋白组织工程支架的人工肝修复材料的培养方法 |
CN106754367A (zh) * | 2016-12-12 | 2017-05-31 | 吉林大学 | 通过静电纺丝制备载药细胞爬片的方法 |
CN106754367B (zh) * | 2016-12-12 | 2019-06-21 | 吉林大学 | 通过静电纺丝制备载药细胞爬片的方法 |
JP2021514680A (ja) * | 2018-03-29 | 2021-06-17 | エースソステム バイオストラテジーズ インコーポレイテッド | ヒト臍帯から幹細胞を分離する方法 |
JP7064254B2 (ja) | 2018-03-29 | 2022-05-10 | エースソステム バイオストラテジーズ インコーポレイテッド | ヒト臍帯から幹細胞を分離する方法 |
CN108823148A (zh) * | 2018-07-23 | 2018-11-16 | 广东唯泰生物科技有限公司 | 一种脂肪间充质干细胞诱导分化为肝脏样细胞的方法 |
Also Published As
Publication number | Publication date |
---|---|
CN102250829B (zh) | 2012-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102250829B (zh) | 人脐带间充质干细胞向肝细胞定向分化的诱导方法 | |
CN103805562B (zh) | 培养胎盘间充质干细胞的无血清培养基 | |
CN104164403B (zh) | 一种提取及培养脂肪干细胞的方法 | |
Pal et al. | Phenotypic and functional comparison of optimum culture conditions for upscaling of bone marrow‐derived mesenchymal stem cells | |
CN102757936B (zh) | 人脂肪干细胞增殖促进剂及其应用方法 | |
CN107299082B (zh) | 从组织中分离胎盘间质细胞并培养成间充质干细胞的方法 | |
Nicoletti et al. | Methods and procedures in adipose stem cells: state of the art and perspective for translation medicine | |
US20180362920A1 (en) | Serum-free culture medium and preparation method and application therefor | |
CN105112366B (zh) | 一种含小檗碱的间充质干细胞无血清培养基 | |
JP2019510509A5 (zh) | ||
CN109234229B (zh) | 从胎盘血管分离间充质干细胞的方法和所用消化酶组合物 | |
CN102978156A (zh) | 一种骨髓间充质干细胞的体外扩增纯化培养方法及培养基 | |
CN105238750B (zh) | 一种复苏脐带间充质干细胞的方法 | |
CN105219707B (zh) | 一种复苏脂肪间充质干细胞的方法 | |
CN102174468A (zh) | 诱导人脐带间充质干细胞分化为睾丸间质细胞的方法与应用 | |
CN104673745A (zh) | 一种猪脂肪干细胞的分离培养方法 | |
CN107653225A (zh) | 一种用于扩增人间充质干细胞的培养基及其扩增方法 | |
CN105420179A (zh) | 一种从脐带和胎盘羊膜组织同时提取上皮细胞和间充质干细胞的方法 | |
CN102433301A (zh) | 一种提取扩增单克隆间充质干细胞的方法及所用培养液 | |
CN104830756A (zh) | 翘嘴红鲌精原干细胞分离培养方法 | |
CN102965330A (zh) | 一种提供多种细胞协同生长的方法 | |
CN104611292A (zh) | 一种脂肪间充质干细胞大规模培养方法 | |
CN110468101A (zh) | 一种骨髓间充质干细胞的增殖培养方法 | |
CN110564675A (zh) | 一种毛囊干细胞的分离提取方法 | |
CN102010850B (zh) | 一种脐带组织间充质干细胞爬片分离的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20111123 Assignee: ALLIANCELLS BIOSCIENCE Co.,Ltd. Assignor: Tianjin Heze Stem Cell Technology Co.,Ltd. Contract record no.: 2012120000065 Denomination of invention: Inducing method for directional differentiation of human umbilical cord mesenchymal stem cells into liver cells Granted publication date: 20120711 License type: Exclusive License Record date: 20121029 |
|
LICC | Enforcement, change and cancellation of record of contracts on the licence for exploitation of a patent or utility model | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20190520 Address after: Room 405, 4th floor, 12 Meiyuan Road, Huayuan Industrial Zone, Tianjin City, 300 457 days Patentee after: Zhongyuan Concorde Biological Cell Storage Service (Tianjin) Co.,Ltd. Address before: 300381 Second Floor 202-B078, Ligang Building, 82 West Second Road, Hexi Airport Economic Zone, Tianjin Patentee before: Tianjin Heze Stem Cell Technology Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120711 |